Connecticut Wealth Management LLC Takes $769,000 Position in Marsh & McLennan Companies, Inc. $MRSH

Connecticut Wealth Management LLC bought a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 4,145 shares of the financial services provider’s stock, valued at approximately $769,000.

A number of other large investors have also modified their holdings of the stock. Vanguard Group Inc. grew its stake in shares of Marsh & McLennan Companies by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 46,589,633 shares of the financial services provider’s stock valued at $8,643,309,000 after buying an additional 387,100 shares in the last quarter. State Street Corp grew its stake in shares of Marsh & McLennan Companies by 0.4% in the third quarter. State Street Corp now owns 21,538,014 shares of the financial services provider’s stock valued at $4,340,556,000 after buying an additional 96,436 shares in the last quarter. Capital International Investors acquired a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at about $3,482,557,000. Capital World Investors grew its stake in shares of Marsh & McLennan Companies by 0.5% in the third quarter. Capital World Investors now owns 17,702,898 shares of the financial services provider’s stock valued at $3,567,410,000 after buying an additional 92,767 shares in the last quarter. Finally, Wellington Management Group LLP grew its stake in shares of Marsh & McLennan Companies by 9.1% in the third quarter. Wellington Management Group LLP now owns 15,091,478 shares of the financial services provider’s stock valued at $3,041,386,000 after buying an additional 1,260,434 shares in the last quarter. Institutional investors and hedge funds own 87.99% of the company’s stock.

Marsh & McLennan Companies Stock Up 0.6%

NYSE:MRSH opened at $168.20 on Friday. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. Marsh & McLennan Companies, Inc. has a 52 week low of $156.60 and a 52 week high of $220.32. The company has a market cap of $81.26 billion, a price-to-earnings ratio of 21.02, a PEG ratio of 2.43 and a beta of 0.62.

Marsh & McLennan Companies (NYSE:MRSHGet Free Report) last released its earnings results on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, topping analysts’ consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The company had revenue of $7.30 billion for the quarter. The firm’s revenue was up 7.6% on a year-over-year basis. As a group, equities analysts expect that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current year.

Insider Buying and Selling

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the transaction, the chief executive officer owned 116,811 shares of the company’s stock, valued at $18,889,506.81. This trade represents a 12.48% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

MRSH has been the subject of a number of recent research reports. Weiss Ratings lowered Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Raymond James Financial raised Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 price target for the company in a report on Tuesday, February 17th. UBS Group reduced their price target on Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating for the company in a report on Tuesday. Citigroup raised Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price target for the company in a report on Wednesday, May 6th. Finally, JPMorgan Chase & Co. reduced their price target on Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating for the company in a report on Thursday, April 9th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Marsh & McLennan Companies has a consensus rating of “Hold” and an average price target of $200.19.

Get Our Latest Analysis on Marsh & McLennan Companies

Marsh & McLennan Companies Profile

(Free Report)

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Featured Stories

Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report).

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MRSH)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.